Fertility Preservation Before Cancer Treatment: Protecting Future Choices
Understanding whether cancer treatment may affect fertility — and what options exist to protect future choices before treatment begins.
When a Diagnosis Raises a New Question
When a person receives a cancer diagnosis, the immediate focus is understandably on treatment.
For younger patients, however, there may be another important conversation that needs to happen very early: could the planned cancer treatment affect future fertility?
Some forms of chemotherapy, radiation, and surgery can impair reproductive function. The level of risk differs between patients and depends on factors such as age, diagnosis, treatment type, dose, and the individual treatment plan.
Fertility preservation should therefore be discussed early when clinically relevant — before treatment begins, whenever medically appropriate.
Not Only a Medical Question
For some patients, the possibility of losing fertility can be emotionally difficult, even if they are not currently planning to have children.
A person may not know whether they want a family in the future. But losing that choice before having the opportunity to make the decision can itself be significant.
Cancer treatment already creates uncertainty and a loss of control. Understanding whether fertility may be affected — and whether preservation options exist — can help patients make an informed decision about their future.
There is no single correct emotional response. Feelings and priorities differ between patients, and may also change over time. What matters is that the conversation is available.
How Cancer Treatment Can Affect Fertility
Cancer treatment does not affect every patient in the same way.
Certain chemotherapy drugs can affect ovarian reserve or sperm production. Radiation involving the reproductive organs can also affect fertility, with the risk depending on location, dose, and individual circumstances.
Fertility risk must therefore be assessed individually, rather than assumed.
Fertility-Preservation Options
For men, sperm cryopreservation before treatment is an established option when medically appropriate.
For women, possible approaches may include oocyte cryopreservation — retrieval and freezing of unfertilized eggs for possible future IVF.
Embryo cryopreservation — fertilization of retrieved eggs and freezing of the resulting embryos for future use.
Ovarian tissue cryopreservation, an option considered in selected situations.
Ovarian transposition — in selected patients receiving pelvic radiation, surgery may be considered to move the ovaries outside the radiation field.
The correct option depends on the patient's age, diagnosis, treatment urgency, reproductive goals, medical suitability, and the recommendations of the relevant specialists.
Timing Matters
Cancer treatment should not be delayed without appropriate medical justification.
However, modern fertility-preservation pathways may allow intervention within a limited timeframe, making early referral and coordination particularly important.
The oncology and fertility teams need to work from the same diagnosis, treatment timetable, and patient priorities.
A Multidisciplinary Conversation
Fertility preservation is not separate from cancer care.
The discussion may involve the treating oncologist, a reproductive-medicine specialist, the patient, and — where appropriate — family members and other relevant professionals.
The objective is not to promise future pregnancy. It is to make sure that a patient who may be at risk of losing fertility has the opportunity to understand the risk and the available options before treatment, whenever medically appropriate.
Preserving More Than Fertility
Cancer treatment is about survival and control of disease. But high-quality care also considers the life a patient hopes to return to after treatment.
For some patients, future parenthood may be part of that life. For others, simply knowing that their options were considered can matter.
RKM INTL's Role
At RKM INTL, our role is coordination — helping international patients and partners access the appropriate medical institutions and specialists, and supporting communication across the treatment pathway.
RKM INTL does not make medical decisions. Diagnosis, fertility recommendations, cancer treatment, and all clinical decisions remain entirely with the relevant physicians and medical institutions.
If cancer treatment may affect fertility, the conversation should happen early — while there may still be options to preserve future choices.
Ready to have your case reviewed?
Send a brief first-contact enquiry, and RKM INTL will coordinate the appropriate next step.
Medical Disclaimer: This content is provided for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. RKM INTL is not a medical provider. Medical decisions should always be made in consultation with a qualified physician or healthcare professional.
Last updated: 2026-09-04